Cystatin C, creatinine, estimated glomerular filtration, and long-term mortality in stroke patients

Renal Failure

Volumn 36, Issue 1, 2014, Pages 81-86

  Hojs Fabjan, Tanja ^a,b   Penko, Meta ^a   Hojs, Radovan ^a,b  

^a UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

^b UNIVERSITY OF MARIBOR   (Slovenia)

Author keywords

Creatinine; Cystatin C; Ischemic stroke; Mortality; Renal dysfunction

Indexed keywords

CREATININE; CYSTATIN C;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; STROKE PATIENT;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; COHORT STUDIES; CREATININE; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; SLOVENIA; STROKE;

EID: 84889582739     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.832314     Document Type: Article

References (49)

1. Bhatnagar P, Scarborough P, Smeeton NC, Allender S. The incidence of all stroke and stroke subtype in the United Kingdom, 1985 to 2008: a systematic review. BMC Public Health. 2010;10:539.
2. Cooper R, Cutler J, Desvigne-Nickens P, et al. Trends and disparities in coronary heart diseases, stroke, and other cardiovascular disease in the United States: findings of the National Conference on cardiovascular Disease Prevention. Circulation. 2000;102(25):3137-3147.
3. Manjunath G, Tighiouart H, Coresh J, et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int. 2003;63(3):1121-1129.
4. Garg AX, Clark WF, Haynes RB, et al. Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Kidney Int. 2002;61(4):1486-1494.
5. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-1305.
6. Kawagishi T, Nishizawa Y, Konishi T, et al. High-resolution Bmode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int. 1995;48(3):820-826.
7. Hojs R. Carotid intima-media thickness and plaques in hemodialysis patients. Artif Organs. 2000;24(9):691695.
8. Seliger SL, Gillen DL, Longstreth Jr WT, Kestenbaum B, Stehman-Breen CO. Elevated risk of stroke among patients with end-stage renal disease. Kidney Int. 2003;64(2):603-609.
9. Tsagalis G, Akrivos T, Alevizaki M, et al. Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality. Nephrol Dial Transplant. 2009;24(1):194-200.
10. Yahalom G, Schwartz R, Schwammenthal Y, et al. Chronic kidney disease and clinical outcome in patients with acute stroke. Stroke. 2009;40(4):1296-1303.
11. Hojs Fabjan T, Hojs R, Tetickovic E, Pecovnik Balon B. Ischemic stroke-impact of renal dysfunction on in-hospital mortality. Eur J Neurol. 2007;14(12):1351-1356.
12. MacWalter RS, Wong SYS, Wong KYK. Does renal dysfunction predict mortality after acute stroke? A 7-year follow-up study. Stroke. 2002;33(6):130-135.
13. Ovbiagele B. Chronic kidney disease and risk of death during hospitalization for stroke. J Neurol Sci. 2011; 301(1-2):46-50.
14. Lee M, Saver JL, Chang KH, Liao HW, Chang SC, Ovbigale B. Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ. 2010;341:c4249.
15. National Kidney Fundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1-266.
16. Froissart M, Rossert J, Jacquot C, et al. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol. 2005; 16(3):763-773.
17. Miller WG. Reporting estimated GFR: a laboratory perspective. Am J Kidney Dis. 2008;52(4):645-648.
18. Hojs R, Bevc S, Ekart R, Gorenjak M, Puklavec L. Kidney function estimating equations in patients with chronic kidney disease. Int J Clin Pract. 2011;65(4):458-464.
19. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). Ann Intern Med. 2009; 150(9):604-612.
20. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a metaanalysis. Am J Kidney Dis. 2002;40(2):221-226.
21. Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of renal function: a review. Clin Chem Lab Med. 1999; 37(4):389-395.
22. Coll E, Botey A, Alvarez L, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000; 36(1):29-34.
23. Finney H, Williams AH, Price CP. Serum cystatin C in patients with myeloma. Clin Chim Acta. 2001;309(1):1-6.
24. Fricker M, Wiesli P, Brundle M, et al. Impact of thyroid dysfunction on serum cystatin C. Kidney Int. 2003; 63(5):1944-1947.
25. Risch L, Herklotz R, Blumberg A, Huber AR. Effects of glucocorticoid immunosuppresion on serum cystatin C concentrations in renal transplant patients. Clin Chem. 2001; 47(11):2055-2059.
26. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352(20):2049-2060.
27. de Boer IH, Katz R, Cao JJ, et al. Cystatin C, albuminuria, and mortality among older adults with diabetes mellitus. Diabetes Care. 2009;32(10):1833- 1838.
28. Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3418 individuals with CKD. Am J Kidney Dis. 2008;51(3):395-406.
29. Ni L, Lü J, Hou LB, et al. Cystatin C, associated with hemorrhagic and ischemic stroke, is a strong predictor of the risk of cardiovascular events and death in Chinese. Stroke. 2007;38(12):3287-3288.
30. Thorvaldsen P, Asplund K, Kuulasmaa K, et al. Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organisation Monitoring Trends and Determinants in Cardiovascular Disease. Stroke. 1995;26(3):361-367.
31. Muir KW, Weir CJ, Murray GD, Povey C, Lees KR. Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke. 1996;27(10):1817-1820.
32. Mazzachi BC, Peake MJ, Ehrhardt V. Reference range and method comparison studies for enzymatic and Jaffé creatinine assay in plasma and serum and early morning urine. Clin Lab. 2000;46(1-2):53-55.
33. Rydén L, Standl E, Bartnik M, et al. Guidelines on diabetes, prediabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007; 28(1):88-136.
34. Mancia G, De Backer G, Dominiczak A, et al. Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25(6):1105-1187.
35. Bevc S, Hojs R, Ekart R, Gorenjak M, Puklavec L. Simple cystatin C formula compared to sophisticated CKD-EPI formulas for estimation of glomerular filtration rate in the elderly. Ther Apher Dial. 2011;15(3):261-268.
36. Bevc S, Hojs R, Ekart R, Zavrs?nik M, Gorenjak M, Puklavec L. Simple cystatin C formula for estimation of glomerular filtration rate in overweight patients with diabetes mellitus type 2 and chronic kidney disease. Exp Diabetes Res. 2012. [Epub ahead of print]. doi:10.1155/2012/179849.
37. Matsushita K, Mahmodi BK, Woodward M, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD Study equation for estimated glomerular filtration risk. JAMA. 2012; 307(18):1941-1951.
38. Astor BC, Levey AS, Stevens LA, Van Lente F, Selvin E, Coresh J. Method of glomerular filtration rate estimation affects prediction of mortality risk. J Am Soc Nephrol. 2009;20(10):2214-2222.
39. Sarnak MJ, Katz R, Stehman-Breen CO, et al. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med. 2005;142(7):497-505.
40. O'Riordan SE, Webb MC, Stowe HJ, et al. Cystatin C improves the detection of mild renal dysfunction in older patients. Ann Clin Biochem. 2003;40(Pt 6):648-655.
41. Ix JH, Shlipak MG, Chertow GM, Whooley MA. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation. 2007;115(2):173-179.
42. Naruse H, Ishii J, Kawai T, et al. Cystatin C in acute heart failure without advanced renal impairment. Am J Med. 2009; 122(6):566-573.
43. Urbonaviciene G, Shi GP, Urbonavicius S, Henneberg EW, Lindholt JS. Higher cystatin C level predicts long-term mortality in patients with peripheral arterial disease. Atherosclerosis. 2011; 216(2):440-445.
44. Keller T, Messow CM, Lubos E, et al. Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study. Eur Heart J. 2009;30(3):314-320.
45. Wu CK, Lin JW, Caffrey JL, Chang MH, Hwang JJ, Lin YS. Cystatin C and long-term mortality among subjects with normal creatinine-based estimated glomerular filtration rates: NHANES III (Third National Health and Nutrition Examination Survey). J Am Coll Cardiol. 2010;56(23):1930-1936.
46. Astor BC, Shafi T, Hoogeveen RC, et al. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population. Am J Kidney Dis. 2012; 59(5):653-662.
47. Astor BC, Shaikh S, Chaundry M. Association of endogenous markers of kidney function with outcomes: more and less than glomerular filtration rate. Curr Opin Nephrol Hypertens. 2013; 22(3):331-335.
48. Seliger SL, Longstreth Jr WT, Katz R, et al. Cystatin C and subclinical brain infarction. J Am Soc Nephrol. 2005; 16(12):3721-3727.
49. Xiao D, Liu H, Zhang H, Luo Y. Impact of cystatin C levels on infarct size and hemorrhage volume in acute cerebral stroke. J Neurol. 2012;259(10):2053-2059.